Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
New words:
accepted, Acid, Ainslee, Ainslie, Athira, Beach, Canal, CM, core, cyber, decided, disruption, divested, editing, Elia, environmental, Florida, generatedin, harmful, Hofmann, Icosovax, ID, inclusion, Kingdom, La, Lakeview, Lee, Marc, Matrix, Maverick, NATA, nearer, Nucleic, overseeing, Palm, Pearl, privacy, racially, remarkable, remit, revoke, Roche, seminal, Showcased, smaller, spend, SQZ, Stamford, streamlined, turnover, Underrepresented, valuation
Removed:
Adrian, assuming, awarded, CEO, Chapter, closed, collateral, commencement, commercialized, demonstrate, DMD, earn, encouraged, existed, expire, grandfathered, incentivize, increase, Insider, involuntarily, Koji, loan, longer, margin, NY, OLE, outcome, pecuniary, pledge, pledged, primary, PRISM, proprietary, reminder, repay, resort, separated, space, sublease, suvodirsen, tiered, Trading, trial, underwritten, unwound, wherewithal, York
Filing tables
Filing exhibits
Associated WVE transcripts
WVE similar filings
Filing view
External links
Exhibit 31.1
CERTIFICATION PURSUANT TO
SECTION 302 OF
THE SARBANES-OXLEY ACT OF 2002
I, Paul B. Bolno, M.D., certify that:
1. | I have reviewed this Amendment No. 1 to Annual Report on Form 10-K/A of Wave Life Sciences Ltd.; and |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
Date: April 28, 2022
/s/ Paul B. Bolno, M.D., MBA |
Paul B. Bolno, M.D., MBA |
President and Chief Executive Officer (principal executive officer) |